Bull
$117.84
情景价格
$96.370
+3.074 (+3.19%)收盘时
HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.
HealthEquity Inc is a good buy right now due to its strong revenue growth and profitability indicators. The company reported a 7% year-over-year revenue increase in Q1, with net income reaching $69.4 million, and a gross margin of 66.05% in Q2. However, the main risk is the recent insider selling trend, which has increased by 213.73% over the last quarter, indicating potential concerns among insiders about the stock's future performance.
BTIG
$115
2026-07-24
BTIG
2026-07-24
目标价
$115
Citizens
$111
2026-06-01
Citizens
2026-06-01
目标价
$111
RBC Capital
$108
2026-05-29
RBC Capital
2026-05-29
目标价
$108
BofA
$125
2026-05-29
BofA
2026-05-29
目标价
$125
BMO Capital
$105
2026-04-09
BMO Capital
2026-04-09
目标价
$105
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

HealthEquity Reports Strong Q2 Earnings but Stock Declines

HealthEquity Reports Strong Earnings but Faces Stock Sell-Off

Healthcare Stocks Decline 1.2% on NYSE

HealthEquity Announces Q2 Fiscal 2027 Earnings Release Plans

Healthcare Affordability Pressure Intensifies for American Workers
HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking. It operates in the Technology sector (SERVICES-BUSINESS SERVICES, NEC industry).
HealthEquity Inc is a good buy right now due to its strong revenue growth and profitability indicators. The company reported a 7% year-over-year revenue increase in Q1, with net income reaching $69.4 million, and a gross margin of 66.05% in Q2. However, the main risk is the recent insider selling trend, which has increased by 213.73% over the last quarter, indicating potential concerns among insiders about the stock's future performance.
10 analysts cover HQY: 9 rate it Buy, 1 Hold and 0 Sell. The average price target is 117.09.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。